LSD Liquid Drops – Lysergic Acid Diethylamide Solution | biosynlab
Product Details Table
| Specification | Details |
|---|---|
| Brand | biosynlab |
| Product Name | LSD Liquid Drops (Lysergic Acid Diethylamide Solution) |
| CAS Number | 50-37-3 |
| IUPAC Name | (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
| Molecular Formula | C₂₀H₂₅N₃O |
| Molecular Weight | 323.44 g/mol |
| Purity | ≥99.0% (HPLC verified) |
| Concentration | 100µg per drop (standard) / 150µg per drop (clinical grade) |
| Appearance | Clear, colorless to slightly amber liquid solution |
| Solvent | Pharmaceutical-grade ethanol (99.8%) or distilled water/ethanol mix |
| Packaging | Amber glass dropper bottle (10ml, 30ml, 50ml) with calibrated pipette |
| Storage | -20°C, protected from light, inert atmosphere |
| Stability | 12 months at -20°C, 3 months at 4°C |
| Intended Use | Analytical reference, neuropharmacology research, psychedelic science |
| Documentation | Certificate of Analysis (CoA), SDS, UV-Vis spectral data |
| Origin | EU-synthesized, GMP-analogue facility |
| Shipping | Cold-chain, temperature-monitored, compliant documentation |
SEO-Optimized Product Description
Introduction: Precision Lysergamide Solutions for Advanced Psychedelic Research
The renaissance in psychedelic science has catalyzed unprecedented demand for high-integrity lysergamide reference materials across academic, clinical, and forensic research institutions. biosynlab meets this scientific imperative with pharmaceutical-grade LSD liquid drops—precisely calibrated lysergic acid diethylamide solutions engineered for volumetric dosing accuracy, analytical method validation, and reproducible neuropharmacological research.
Originally synthesized by Albert Hofmann at Sandoz Laboratories in 1938, LSD has evolved from psychiatric exploratory tool to a rigorously studied compound with FDA Breakthrough Therapy designation for depression and anxiety treatment. biosynlab’s liquid formulation provides researchers across USA, European Union, and United Kingdom with the precision required for microdosing protocols, receptor binding assays, and quantitative pharmacokinetic studies.
Industrial Applications & Research Methodologies
biosynlab’s LSD liquid solutions support cutting-edge research across multiple scientific domains:
Neuropharmacology & Receptor Pharmacology
Research institutions investigating 5-HT₂A receptor agonism, default mode network modulation, and neuroplasticity mechanisms require precisely dosed LSD for in-vitro binding studies, fMRI neuroimaging correlations, and serotonin receptor subtype selectivity profiling.
Psychedelic Science & Clinical Research
With Johns Hopkins, Imperial College London, and NYU conducting Phase II/III clinical trials, standardized LSD solutions are essential for dose-response studies, therapeutic outcome measurement, and pharmacokinetic modeling. biosynlab’s 100µg and 150µg per drop concentrations align with established research protocols.
Forensic Toxicology & Analytical Chemistry
Toxicology laboratories utilize biosynlab LSD standards for LC-MS/MS method development, biological matrix quantification (blood, urine, hair), and seized substance identification. Our high-purity solutions serve as calibration standards for forensic confirmation testing.
Microdosing Research & Sub-Perceptual Dosing Studies
Academic investigations into sub-hallucinogenic dosing (5-20µg) for cognitive enhancement, mood regulation, and creativity research require volumetric precision that only calibrated liquid solutions provide. biosynlab’s dropper bottles enable accurate fractional dosing for controlled microdosing protocols.
Chemical Characteristics & Solution Mechanics
biosynlab produces LSD liquid drops through advanced lysergamide chemistry ensuring stability, potency consistency, and analytical traceability.
Key Chemical Properties:
- Mechanism: Potent 5-HT₂A receptor agonist, partial agonist at 5-HT₁A/2B/2C
- Potency: Active in microgram quantities (threshold ~10µg, full dose 100-200µg)
- Chirality: (5R,8R)-(+)-LSD is the active enantiomer
- Stability: Light-sensitive, stable in ethanol at low temperatures
- Metabolism: Hepatic via CYP2D6, 2C19; active metabolites include 2-oxo-3-hydroxy-LSD
Our volumetric solution preparation protocol includes:
- High-performance liquid chromatography (HPLC) purity verification ≥99.0%
- Gravimetric dosing accuracy ±2% per drop
- Homogeneous distribution verification via UV-Vis spectrophotometry
- Sterile filtration (0.22µm) for solution clarity
- Amber glass packaging with nitrogen headspace to prevent oxidative degradation
Each batch is accompanied by comprehensive Certificate of Analysis documenting:
- Chromatographic purity and impurity profiling
- Concentration verification via UV-Vis and HPLC
- Sterility testing (where applicable)
- Endotoxin levels
- pH measurement
- Osmolality (for aqueous formulations)
Volumetric Dosing Precision & Research Applications
biosynlab’s calibrated dropper system delivers research-grade precision:
Standard Concentrations:
- 100µg per drop: Ideal for microdosing research, sub-perceptual studies, and dose titration protocols
- 150µg per drop: Clinical-grade concentration for full psychedelic dosing studies, therapeutic research, and neuroimaging correlation studies
Volumetric Advantages for Research:
- Precision: Eliminates variability associated with blotter paper absorption
- Flexibility: Enables fractional dosing (50µg = 0.5 drops calibrated)
- Stability: Ethanol solutions demonstrate superior shelf-life vs. paper matrices
- Sterility: Reduced contamination risk compared to solid dosage forms
- Quantification: Easier extraction for analytical confirmation testing
Research Protocol Integration:
- Compatible with established Johns Hopkins/Imperial College dosing methodologies
- Supports double-blind placebo-controlled trial designs
- Facilitates personalized dosing based on body weight (µg/kg calculations)
- Enables consistent dosing across multi-site clinical trials
Geographic Distribution & Research Institution Coverage
biosynlab supplies leading psychedelic research centers globally:
United States Research Institutions:
- Baltimore: Johns Hopkins Center for Psychedelic & Consciousness Research
- New York: NYU Langone Psychiatry psychedelic studies
- San Francisco: UCSF Neuroscape psychedelic science laboratory
- Boston: Massachusetts General Hospital psychiatric research
- Seattle: UW Medicine psychedelic-assisted therapy research
European Union Research Centers:
- London: Imperial College London Centre for Psychedelic Research
- Zurich: University Hospital of Psychiatry psychedelic studies
- Barcelona: Sant Pau Hospital psychedelic research program
- Berlin: Charité – Universitätsmedizin Berlin psychiatric research
- Amsterdam: University of Amsterdam psychopharmacology department
United Kingdom Academic Centers:
- Oxford: Oxford Psychedelic Society research collaborations
- Cambridge: University of Cambridge neuroscience research
- Manchester: University of Manchester psychopharmacology unit
- Edinburgh: University of Edinburgh clinical psychiatry research
- Bristol: University of Bristol psychedelic research
